| You are in:Home/Publications/Arginine Dimethylation Products in Pediatric Patients with Chronic Kidney Disea | |
Prof. ahmed abdelftah azab :: Publications: |
|
| Title: | Arginine Dimethylation Products in Pediatric Patients with Chronic Kidney Disea |
| Authors: | Akram E. El-Sadek, MD, Lecturer of pediatrics, Eman G. Behery, MD, Ahmed A. Azab, MD, Associate Professor of pediatrics, Naglaa M. Kamal, MD, Associate Professor of pediatrics, Mostafa A. Salama, MD, Associate Professor of pediatrics, Waleed E. Abdulgh |
| Year: | 2016 |
| Keywords: | Annals of Medicine and Surgery |
| Journal: | Annals of Medicine and Surgery |
| Volume: | Not Available |
| Issue: | Not Available |
| Pages: | Not Available |
| Publisher: | Not Available |
| Local/International: | International |
| Paper Link: | Not Available |
| Full paper | Not Available |
| Supplementary materials | Not Available |
| Abstract: |
Background: arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD). We aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function. Patients and Methods: 132 pediatric patients with CKD and 120 healthy age and sex matched controls were compared regarding; serum Arg, ADMA and SDMA levels. Results: In comparison to their values in control subjects, serum Arg levels were significantly lower; serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in CKD patients (p values: < 0.000; =0.054; |
